BRPI0514836A - uso de toxina botulìnica para tratamento de uma deformidade da nádega - Google Patents

uso de toxina botulìnica para tratamento de uma deformidade da nádega

Info

Publication number
BRPI0514836A
BRPI0514836A BRPI0514836-7A BRPI0514836A BRPI0514836A BR PI0514836 A BRPI0514836 A BR PI0514836A BR PI0514836 A BRPI0514836 A BR PI0514836A BR PI0514836 A BRPI0514836 A BR PI0514836A
Authority
BR
Brazil
Prior art keywords
treat
buttock deformity
botulinum toxin
buttock
deformity
Prior art date
Application number
BRPI0514836-7A
Other languages
English (en)
Inventor
Eric R First
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0514836A publication Critical patent/BRPI0514836A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Abstract

USO DE TOXINA BOTULìNICA PARA TRATAMENTO DE UMA DEFORMIDADE DA NáDEGA. Métodos para tratar uma deformidade da nádega ou para prevenir o desenvolvimento de uma deformidade da nádega por administração local de uma toxina Clostrídica, tal como, neurotoxina botulínica, a uma deformidade da nádega ou ao redor de uma deformidade da nádega.
BRPI0514836-7A 2004-09-03 2005-08-24 uso de toxina botulìnica para tratamento de uma deformidade da nádega BRPI0514836A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/934,810 US7179474B2 (en) 2004-09-03 2004-09-03 Methods for treating a buttock deformity
PCT/US2005/032065 WO2006029287A1 (en) 2004-09-03 2005-08-24 Use of a botulinum toxin for treating a buttock deformity

Publications (1)

Publication Number Publication Date
BRPI0514836A true BRPI0514836A (pt) 2008-06-24

Family

ID=35539707

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514836-7A BRPI0514836A (pt) 2004-09-03 2005-08-24 uso de toxina botulìnica para tratamento de uma deformidade da nádega

Country Status (5)

Country Link
US (4) US7179474B2 (pt)
KR (1) KR101234459B1 (pt)
AU (1) AU2005282409A1 (pt)
BR (1) BRPI0514836A (pt)
WO (1) WO2006029287A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
US7179474B2 (en) * 2004-09-03 2007-02-20 Allergan, Inc. Methods for treating a buttock deformity
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
US9782617B2 (en) 2010-09-19 2017-10-10 Thomas Alan Ferguson, JR. Piri-stretcher system
US9101794B2 (en) 2010-09-19 2015-08-11 Thomas Alan Ferguson, JR. Piri-stretcher
CN103702681A (zh) * 2011-07-20 2014-04-02 阿勒根公司 用于治疗脂肪沉积的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183462A (en) * 1990-08-21 1993-02-02 Associated Synapse Biologics Controlled administration of chemodenervating pharmaceuticals
CH685129A5 (fr) * 1991-03-01 1995-03-31 Speno International Dispositif pour le reprofilage des rails d'une voie ferrée.
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US5670484A (en) 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
DK0758900T3 (da) * 1994-05-09 2002-07-29 William J Binder Botulinumtoksin til reduktion af migræne-hovedpinesmerter
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
SE505462C2 (sv) * 1995-10-11 1997-09-01 Lidstroem Ab K Seriematat ljusövervakningssystem
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
PT1011695E (pt) * 1997-07-15 2006-07-31 Univ Colorado Utilizacao de terapia com neurotoxina para tratamento de doencas da prostata
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
GB9818548D0 (en) 1998-08-25 1998-10-21 Microbiological Res Authority Treatment of mucas hypersecretion
TW574036B (en) 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin
AU1706400A (en) * 1998-10-27 2000-05-15 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
GB9907429D0 (en) 1999-03-31 1999-05-26 Microbiological Res Authority Modulation of C-fibre activity
DE19925739A1 (de) 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
GB9922554D0 (en) 1999-09-23 1999-11-24 Microbiological Res Authority Inhibition of secretion from non-neuronal cells
US6113915A (en) * 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6265379B1 (en) * 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) * 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6261572B1 (en) * 2000-01-11 2001-07-17 Allergan Sales, Inc. Method for treating a pancreatic disorder with a neurotoxin
US6143306A (en) * 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) * 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
WO2003011333A1 (en) 2001-07-27 2003-02-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Botulinum toxin in the treatment or prevention of acne
US6623742B2 (en) * 2001-09-17 2003-09-23 Allergan, Inc. Methods for treating fibromyalgia
US20030224019A1 (en) * 2002-03-01 2003-12-04 O'brien Christopher Methods of treating nerve entrapment syndromes
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7393537B2 (en) * 2003-04-25 2008-07-01 Allergan, Inc. Botulinum toxin for treatment of obsessive compulsive finger biting disorder
US7179474B2 (en) * 2004-09-03 2007-02-20 Allergan, Inc. Methods for treating a buttock deformity

Also Published As

Publication number Publication date
AU2005282409A1 (en) 2006-03-16
US20060051341A1 (en) 2006-03-09
US7179474B2 (en) 2007-02-20
US7438921B2 (en) 2008-10-21
KR101234459B1 (ko) 2013-02-18
US20070128228A1 (en) 2007-06-07
WO2006029287A1 (en) 2006-03-16
US20080152672A1 (en) 2008-06-26
US20080152739A1 (en) 2008-06-26
KR20070051931A (ko) 2007-05-18

Similar Documents

Publication Publication Date Title
WO2006138059A3 (en) Treatment of autoimmune disorders with a neurotoxin
MXPA03002576A (es) Metodos para tratar lesiones musculares.
MX2019000151A (es) Una neurotoxina botulinica novedosa y sus derivados.
BRPI0417493B8 (pt) uso de uma toxina botulínica para tratamento de distúrbios da pele
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
DK1784205T3 (da) Strækmærkebehandling med botulinumtoksin
CL2007001911A1 (es) Uso de un componente neurotoxico de un complejo de toxina de clostridium botulinum, en donde la composicion carece de cualquier otro componente proteico del complejo para tratar una afeccion asociada con la inervacion colinergica muscular hiperactiva
AR028939A1 (es) Metodo para tratar un desorden pancreatico con una neurotoxina
BRPI0515352A (pt) métodos para tratamento de cáncer
BRPI0514836A (pt) uso de toxina botulìnica para tratamento de uma deformidade da nádega
RS52102B (en) PIRPHENIDONE THERAPY Avoiding FLUVOXAMINE
BR0307496A (pt) Uso de uma neurotoxina clostridiana, bem como composição farmacêutica utilizável no tratamento de um distúrbio da glândula mamária
ECSP10010042A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
NZ585108A (en) Methods of treating urogenital-neurological disorders using modified clostridial toxins
WO2010014854A3 (en) Antibodies that neutralize botulinum neurotoxins
BRPI0516398A (pt) método de terapia de manutenção, métodos de tratamento, método para prevenir a recorrência da acne vulgar e usos de adapaleno
CY1114792T1 (el) Κλωστριδιακες τοξινες για χρηση στην θεραπεια προωρης εκσπερματισης
MX2020011816A (es) Metodo para purificar la neurotoxina clostridial.
BR112012008004A2 (pt) compostos e composições como moduladores da atividade de gpr119
RS54863B1 (sr) Upotreba sredstva za suzbijanje vlažne truleži i postupak suzbijanja iste
MX2022010186A (es) Neurotoxinas botulinas para uso en terapia.
PH12019502721A1 (en) Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
AR060088A1 (es) Metodos para tratar trastornos cognitivos y otros afines
BR112016025333A2 (pt) agente, produto e uso
AR106538A1 (es) Métodos y composiciones para el tratamiento de la amiloidosis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 INCISO VIII DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]